Our investment teams
Our experts
Filter by team:
- BB Biotech
- Medtech
- Thematic
- Healthcare Global
- Healthcare Regional
- Listed Small & Mid Sized Entrepreneur Investments
- Multi Asset
BB Biotech
Head BB Biotech Team
Dr. Christian Koch
Head BB Biotech Team
Dr. Christian Koch
Dr Christian Koch has been a portfolio manager at Bellevue Asset Management since 2014. From 2013-2014 he was a sell-side Pharma & Biotech equity analyst at Bank am Bellevue in Küsnacht and from 2010-2013 a Research Associate at the Institute of Pharmaceutical Sciences at ETH Zurich. He holds a PhD in Computer-Assisted Drug Design from ETH Zurich and studied Bioinformatics from Goethe University Frankfurt.
Head Research
Dr. Kyle Rasbach
Head Research
Dr. Kyle Rasbach
Dr. Kyle Rasbach joined Bellevue Research Inc / New York in September 2025. Previously, he held senior positions at Eventide Asset Management, Pappas Capital, Lexeo Therapeutics, Zentalis Pharmaceuticals, and T. Rowe Price. He earned a PhD and PharmD in Pharmacology and Pharmacy from the Medical University of South Carolina and an MBA from The Citadel.
Investment Analyst
Dr. Maurizio Bernasconi
Investment Analyst
Dr. Maurizio Bernasconi
Dr. Maurizio Bernasconi joined Bellevue Asset Management as analyst and portfolio manager in 2017. Prior he was a sell-side equity analyst in the Pharma & Biotech department of Bank am Bellevue. Maurizio Bernansconi has a master's degree in chemistry at Swiss Federal Institute of Technology (ETH), Zurich, and has PhD in organic chemistry at the University of Basel.
Investment Analyst
Dr. Jordan Baumhardt
Investment Analyst
Dr. Jordan Baumhardt
Dr. Jordan Baumhardt joined Bellevue Research Inc / New York in October 2025 as Investment Analyst. Prior to joining Bellevue, he held roles at Lexeo Therapeutics, Zentalis Pharmaceuticals, Eventide Asset Management, and LifeSci Capital. He holds a PhD in Pharmacology and Molecular Biophysics from the University of Texas Southwestern Medical Center and a BSc in Biochemistry and Molecular Biology from Illinois State University.
Investment Analyst
Dr. Anna Guinot Aguado
Investment Analyst
Dr. Anna Guinot Aguado
Dr. Anna Guinot Aguado joined Bellevue Asset Management in 2024. She previously worked at Nextech Invest, a European Biotech VC focused on oncology, where she gained investment experience in both private and public markets. Before her time at Nextech, Anna completed a PostDoc at the University Children's Hospital Zurich (Kispi) in the Oncology division and at the institute of physiology at the University of Zurich. She holds a PhD in Stem Cell & Cancer Biology from the University of Cambridge, after studying Biochemistry in Valencia and Molecular & Cell Biology in Paris.
Head AI
Sébastien Pires
Head AI
Sébastien Pires
Sébastien Pires has been Head of AI BB Biotech at Bellevue Asset Management since 2026, where he is responsible for the development and implementation of AI-driven solutions as well as leading related engineering initiatives. Prior to joining Bellevue, he served as VP Engineering at AllianceBernstein from 2023, where he developed AI-based applications to automate fundraising processes and trade reconciliation systems, and drove the modernization of system architecture and infrastructure. From 2019 to 2023, he was Technical Lead at Insig AI in London, where he developed core platforms and ESG analytics solutions. Previously, he worked as a Senior Software Engineer at Ryalto and Babylon Health, focusing on scalable platforms in the healthcare sector. He began his career as a Software Engineer at Sebia Group in London and as an IT Engineer at Solutys Group in Paris. Sébastien Pires holds a Master of Science in Computer Science from the University of Essex.
AI Scientist
Dr. Olivia Woolley
AI Scientist
Dr. Olivia Woolley
Dr. Olivia Woolley joined Bellevue Asset Management as data scientist in 2022. She is a member of the investment management team of BB Biotech. Previously she was associate director data science at Novartis, working in Technical Research and Development. Before entering industry she was a postdoctoral researcher at the Swiss Federal Institute of Technology (ETH), Zurich, in the area of digital epidemiology and complex networks. Olivia holds a PhD and MSc in Applied Mathematics from Northwestern University and a BSc in Mathematical and Computational Science from Stanford University.
AI Engineer
Dr. Can Buldun-Gora
AI Engineer
Dr. Can Buldun-Gora
Dr. Can Buldun-Gora joined Bellevue Asset Management as Data Scientist in 2022. He is a member of the investment management team of BB Biotech. From 2018 to 2022 he was a Computational Scientist at Roche Pharma Research & Early Development, focusing on data science and software solutions for next-generation antibody engineering. Can Buldun-Gora holds a PhD in Biochemistry from the University of Oxford and a BSc in Biochemistry & Cell Biology from Jacobs University Bremen.
Portfolio & Trading Specialist
Xinya Guo
Portfolio & Trading Specialist
Xinya Guo
Xinya Guo is a Portfolio & Trading Specialist for BB Biotech at Bellevue Asset Management. Prior to this, she founded Bridge Quantamental Capital Management in 2025 and served as Chief Investment Officer, where she was responsible for the investment strategy of an equity long/short fund. From 2022 to 2024, she was Vice President and Multi-Asset Execution Trader at the Government of Singapore Investment Corporation (GIC) in London. Previously, she worked at HSBC, most recently as Associate Director in ETF & Delta One Trading, and earlier in CEEMEA Cash Equity Trading as well as a Prime Risk Analyst within Global Markets. Xinya Guo holds an MSc in Risk Management and Financial Engineering from Imperial College Business School and a BSc in Mathematics with Finance from the University of Liverpool.
Medtech
Portfolio Manager
Marcel Fritsch
Portfolio Manager
Marcel Fritsch
Marcel Fritsch has been with Bellevue Asset Management since 2008. He is head of healthcare funds & mandates and co-lead portfolio manager of the Bellevue Medtech & Services, Bellevue Digital Health and Bellevue AI Health funds. Prior to that, he worked as a consultant at Deloitte Touche Tohmatsu for over 3 years. His tasks in this function included analysis of business strategies, assessment of organizational structures and the valuation of companies in the run-up to corporate transactions. Marcel Fritsch holds a degree in business administration from the University of St. Gallen (HSG).
Portfolio Manager
Stefan Blum
Portfolio Manager
Stefan Blum
Stefan Blum joined Bellevue Asset Management in 2008 and is co-lead portfolio manager of the funds Bellevue Medtech & Services, Bellevue Digital Health and Bellevue AI Health. Prior to joining Bellevue Asset Management, he spent 4 years as head of investor relations at Sonova. As a financial analyst at Bank Sarasin, he covered medical technology and high tech stocks. After that he served as CFO of Obtree Technologies Inc. Stefan Blum obtained a degree in business administration from the University of St. Gallen and is CEFA charterholder.
Senior Equity Analyst
Catharina Claes
Senior Equity Analyst
Catharina Claes
Catharina Claes joined Bellevue Asset Management in 2023 as a Healthcare equity analyst. Previously, she spent almost four years covering German small and mid cap stocks, most recently at Berenberg in London for three years. Catharina Claes holds an MSc in Financial Economics from City University of London and a BSc in Economics from the University of Cologne.
Thematic
Portfolio Manager
Stefan Blum
Portfolio Manager
Stefan Blum
Stefan Blum joined Bellevue Asset Management in 2008 and is co-lead portfolio manager of the funds Bellevue Medtech & Services, Bellevue Digital Health and Bellevue AI Health. Prior to joining Bellevue Asset Management, he spent 4 years as head of investor relations at Sonova. As a financial analyst at Bank Sarasin, he covered medical technology and high tech stocks. After that he served as CFO of Obtree Technologies Inc. Stefan Blum obtained a degree in business administration from the University of St. Gallen and is CEFA charterholder.
Portfolio Manager
Marcel Fritsch
Portfolio Manager
Marcel Fritsch
Marcel Fritsch has been with Bellevue Asset Management since 2008. He is head of healthcare funds & mandates and co-lead portfolio manager of the Bellevue Medtech & Services, Bellevue Digital Health and Bellevue AI Health funds. Prior to that, he worked as a consultant at Deloitte Touche Tohmatsu for over 3 years. His tasks in this function included analysis of business strategies, assessment of organizational structures and the valuation of companies in the run-up to corporate transactions. Marcel Fritsch holds a degree in business administration from the University of St. Gallen (HSG).
Portfolio Manager
Dr. Terence McManus
Portfolio Manager
Dr. Terence McManus
Dr Terence McManus joined Bellevue Asset Management in 2022 and is lead portfolio manager of the funds Bellevue Diversified Healthcare, Bellevue Healthcare Strategy/Sustainable and portfolio manager of the Bellevue Obesity Solutions fund. Prior to this, he has 12 years of experience within healthcare-specific investing and analysis at Jefferies Investment Bank, Credit Suisse, Julius Baer and most recently at J. Safra Sarasin where he managed a sustainable health fund. Terence started his career as a scientist focused on drug discovery. He holds a PhD in Neuroscience from the University of Southampton, UK.
Senior Equity Analyst
Guy Bettschart
Senior Equity Analyst
Guy Bettschart
Guy Bettschart joined Bellevue Asset Management in 2025 as a Senior Equity Analyst. Previously, he spent two years as a buy-side healthcare analyst at Kieger AG and worked for Julius Baer in Zurich as a member of its equity research Team. Bettschart holds a BA in Banking & Finance from the University of Zurich and an MSc in Finance from the University of Lausanne and is a CFA Charterholder.
Equity Analyst
Dr. Markus Schweiger
Equity Analyst
Dr. Markus Schweiger
Dr. Markus Schweiger joined Bellevue Asset Management in 2025 as an Equity Analyst. Previously, he worked for Oppenheimer & Co. in New York for two years as a biotech analyst. He holds a PhD in cancer biology (Vrije Universiteit Amsterdam / Massachusetts General Hospital), a dual MSc in neuroscience (Berlin/Amsterdam) and a BSc in psychology.
Healthcare Global
Portfolio Manager
Dr. Terence McManus
Portfolio Manager
Dr. Terence McManus
Dr Terence McManus joined Bellevue Asset Management in 2022 and is lead portfolio manager of the funds Bellevue Diversified Healthcare, Bellevue Healthcare Strategy/Sustainable and portfolio manager of the Bellevue Obesity Solutions fund. Prior to this, he has 12 years of experience within healthcare-specific investing and analysis at Jefferies Investment Bank, Credit Suisse, Julius Baer and most recently at J. Safra Sarasin where he managed a sustainable health fund. Terence started his career as a scientist focused on drug discovery. He holds a PhD in Neuroscience from the University of Southampton, UK.
Senior Equity Analyst
Catharina Claes
Senior Equity Analyst
Catharina Claes
Catharina Claes joined Bellevue Asset Management in 2023 as a Healthcare equity analyst. Previously, she spent almost four years covering German small and mid cap stocks, most recently at Berenberg in London for three years. Catharina Claes holds an MSc in Financial Economics from City University of London and a BSc in Economics from the University of Cologne.
Senior Equity Analyst
Guy Bettschart
Senior Equity Analyst
Guy Bettschart
Guy Bettschart joined Bellevue Asset Management in 2025 as a Senior Equity Analyst. Previously, he spent two years as a buy-side healthcare analyst at Kieger AG and worked for Julius Baer in Zurich as a member of its equity research Team. Bettschart holds a BA in Banking & Finance from the University of Zurich and an MSc in Finance from the University of Lausanne and is a CFA Charterholder.
Senior Equity Analyst
Dr. Annie Zeng
Senior Equity Analyst
Dr. Annie Zeng
Dr Annie Zeng joined Bellevue Asset Management in 2023 as a Healthcare equity analyst. Previously, she spent 2 years as pharma analyst at Bernstein in London covering EU and HK stocks. She also spent 1.5 years at Canaccord-Results as Healthcare investment banking analyst. Annie Zeng holds a PhD degree in Pharmacology from the University of Cambridge.
Healthcare Regional
Portfolio Manager
Marcel Fritsch
Portfolio Manager
Marcel Fritsch
Marcel Fritsch has been with Bellevue Asset Management since 2008. He is head of healthcare funds & mandates and co-lead portfolio manager of the Bellevue Medtech & Services, Bellevue Digital Health and Bellevue AI Health funds. Prior to that, he worked as a consultant at Deloitte Touche Tohmatsu for over 3 years. His tasks in this function included analysis of business strategies, assessment of organizational structures and the valuation of companies in the run-up to corporate transactions. Marcel Fritsch holds a degree in business administration from the University of St. Gallen (HSG).
Senior Equity Analyst
Dr. Annie Zeng
Senior Equity Analyst
Dr. Annie Zeng
Dr Annie Zeng joined Bellevue Asset Management in 2023 as a Healthcare equity analyst. Previously, she spent 2 years as pharma analyst at Bernstein in London covering EU and HK stocks. She also spent 1.5 years at Canaccord-Results as Healthcare investment banking analyst. Annie Zeng holds a PhD degree in Pharmacology from the University of Cambridge.
Listed Small & Mid Sized Entrepreneur Investments
Portfolio Manager
Birgitte Olsen
Portfolio Manager
Birgitte Olsen
Birgitte Olsen, CFA, Head Entrepreneur Investments, joined Bellevue Asset Management in 2008. Prior to that, she was Deputy Head of Portfolio Management Equities Europe at Generali Investments in Cologne for more than nine years. She worked as a Fund Manager (DE and Scandinavia) at Vontobel Asset Management in Zurich in 1997 and 1998. Birgitte Olsen started her career in the financial industry in 1994 as a sell-side analyst at Bank am Bellevue covering the insurance and pharmaceutical sectors. She holds a degree in Finance and Accounting from the University of St. Gallen.
Portfolio Manager
Laurent Picard
Portfolio Manager
Laurent Picard
Laurent Picard joined Bellevue Asset Management in 2018. Prior to that, he was an Financial consultant for start-ups in the internet/tech sector. From 2009 to 2016 he was a senior equity research analyst for media at Société Générale, having joined from UBS Warburg, where he was an equity analyst for IT Services and Software and a strategist specialized on the French markets. Laurent Picard graduated from Paris X University and ESSEC business school and holds a Master of Financial Techniques.
Portfolio Manager
Eduardo Bravo
Portfolio Manager
Eduardo Bravo
Eduardo Bravo joined Bellevue Asset Management in 2025 as a portfolio manager within the Entrepreneur Investment team. Prior to that, he spent ten years at Alantra’s EQMC fund in Madrid, where he was responsible for the healthcare sector. Eduardo began his career as a Corporate Finance Junior Analyst at BNP Paribas. He holds a degree in Business Administration from CUNEF University in Madrid.
Multi Asset
Portfolio Manager
Dr. Malek Bou-Diab
Portfolio Manager
Dr. Malek Bou-Diab
Malek Bou-Diab joined the Bellevue Global Macro team as Portfolio Manager in August 2024. He joined Bellevue Asset Management in 2009 as Senior Portfolio Manager Frontier Markets and Quant Analyst. Prior to that, he worked as Portfolio Manager at Julius Baer in the Emerging Markets team. From 2003 to 2007 he worked as a quantitative risk analyst at Deutsche Bank AG in London. He completed his PhD thesis in theoretical physics at the Swiss Federal Institute of Technology Zurich (ETH) between 1999 and 2003.
Portfolio Manager
Alexandrine Jaecklin
Portfolio Manager
Alexandrine Jaecklin
Alexandrine Jaecklin joined Bellevue Asset Management in June 2015 as portfolio manager in charge of the bond selection. Before, Alexandrine worked for 15 years at UBS. She joined UBS as a credit analyst for Emerging Markets on the sell side in New York and London, and then moved to the Wealth Management in Zürich to cover European Financial credits. She spent the last 6 years of her time at UBS advising directly institutional private clients with a focus on bond markets on managing their portfolio. Prior to UBS, she was an research analyst at Laidlaw Global Securities (New York), Smith Barney (New York), and the United Overseas Bank (BNP subsidiary - Geneva) in the fields of Emerging Markets and fixed income. She holds a Master in International Relations, Economics section, from the Graduate Institute of International Studies (HEI) in Geneva.
Portfolio Manager
Stefan Köhling
Portfolio Manager
Stefan Köhling
Stefan Köhling has been a portfolio manager and strategist at Bellevue Asset Management (Deutschland) GmbH since the beginning of 2023. Previously, he was an investment strategist in Wealth Management at Deutsche Bank. He started his career at the private bank Hauck und Aufhäuser as a multi-asset portfolio manager. Stefan holds a Bachelor's and a Master's degree in Economics and is a CFA charterholder.
Head Investments
Markus Peter
Head Investments
Markus Peter
Markus Peter was appointed CEO of Bellevue Asset Management in June 2025. He has been Head Investments at Bellevue Asset Management since 2009 and a member of the Group Executive Board since 2024. He previously held several management positions during his 10 years with Julius Baer Group, including head product management and development, investment advisory as well as a product specialist for absolute return products. Prior to joining Julius Baer he was employed by IBM, treasury and project finance, as well as by Swiss Bank Corporation, equity and equity derivative trading. Markus Peter holds a master in business economics from the University of St. Gallen (HSG).
